Clearside Biomedical Announces Plan To Explore Strategic Alternatives To Advance Its Proprietary Suprachoroidal Space (Scs®) Delivery Platform And Promising Ophthalmology Pipeline

Reuters
17 Jul
Clearside Biomedical Inc ::
*CLEARSIDE BIOMEDICAL ANNOUNCES PLAN TO EXPLORE STRATEGIC ALTERNATIVES TO ADVANCE ITS PROPRIETARY SUPRACHOROIDAL SPACE (SCS®) DELIVERY PLATFORM AND PROMISING OPHTHALMOLOGY PIPELINE
*CLEARSIDE BIOMEDICAL INC: ALTERNATIVES COULD INCLUDE SALE, LICENSE, MONETIZATION, DIVESTITURE OF ONE OR MORE OF ASSETS, AMONG OTHERS

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 17-JUL-202511:05:00.043 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10